JERUSALEM, Jan. 7, 2025 /PRNewswire/ -- Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a…
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…
Independent director, Jim Alecxih, Chief Executive Officer of DH Medical joins Lumicell's Board of Directors NEWTON, Mass., Jan. 6, 2025…
Bringing decades of clinical leadership to advance symplr's healthcare operations solutions and support patient-centered care HOUSTON, Jan. 6, 2025 /PRNewswire/…
Proceeds from the financing will be used to broaden and improve the company's offerings and for operational expansion across facilities,…
NORTHAMPTON, MA / ACCESSWIRE / January 6, 2025 / Clinical trials are essential for the development of health care products,…
– Approximately $10 million additional investment in private placement equity financing – – $1.5 million from CIRM grant first announced…
SEATTLE and VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…
• PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications • NAYA aiming…